Cornell University Assigned Patent
Copyright © Targeted News Service 2016
2016-10-06
ALEXANDRIA, Va., Oct. 6 -- Cornell University, Ithaca, New York, has been assigned a patent (9,458,213) developed by three co-inventors for "compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript." The co-inventors are Mark A. Rubin, New York, Dorothee Pflueger, Zurich, and David S. Rickman, New York.
The patent application was filed on Feb. 19, 2010 (13/202,207). The full-text of the patent can be found at http://patft.uspto.g . . .
The patent application was filed on Feb. 19, 2010 (13/202,207). The full-text of the patent can be found at http://patft.uspto.g . . .